RxDoctor Payments Data

Christopher Barnard, PA

Physician Assistant · Ann Arbor, MINPI 1740685320

Payments from drug & device makers

$1,038in general payments, 2019–2025

Across 63 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$228
  • Biohaven Pharmaceutical Holding Company Ltd.$155
  • Lilly USA, LLC$152
  • Astellas Pharma US Inc$87
  • AbbVie$85
  • Otsuka America Pharmaceutical, Inc.$73
  • plus $258 from 9 others

What the payments were for

  • Food & beverage$1,038100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,038 in reported general payments places this provider in the 75th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$43,359
Medicare patients
154
Services billed
645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban66$55,022
JardianceEmpagliflozin33$41,331
MounjaroTirzepatide25$29,354
TrulicityDulaglutide18$23,081
JanuviaSitagliptin Phosphate22$21,129
OzempicSemaglutide16$19,729
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$17,650
MyrbetriqMirabegron33$14,634
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$10,469
XareltoRivaroxaban11$9,593
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$5,211
Potassium Chloride122$4,896
VyzultaLatanoprostene Bunod14$3,742
Gabapentin133$2,289
Levothyroxine Sodium180$2,193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$41$55,02266 claims
Lilly USA, LLCMounjaro, Trulicity, Olanzapine$152$53,17598 claims
Boehringer IngelheimJardiance$15$41,33133 claims
Novo NordiskOzempic$228$19,72916 claims
GSKTrelegy Ellipta$32$17,65019 claims
Astellas Pharma US IncMyrbetriq$87$14,63433 claims
AstraZenecaBreztri Aerosphere$68$10,46912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →